1993
DOI: 10.1111/j.1365-2141.1993.tb04710.x
|View full text |Cite
|
Sign up to set email alerts
|

The β+ IVS, I‐NT no. 6 (T→C) thalassaemia in heterozygotes with an associated Hb Valletta or Hb S heterozygosity in homozygotes from Malta

Abstract: In vitro DNA amplification and dot blot analysis with synthetic allele specific oligonucleotides (ASO) identified the beta + IVS, I-6 (T --> C) thalassaemia in 78% of 32 chromosomes from 16 beta-thalassaemia homozygotes in Malta. The preponderance of a single thalassaemia mutation in one population is unusual. The beta + IVS, I-6C thalassaemia mutation was also found in three carriers who had an associated beta globin heterozygosity, i.e. Hb Valletta (or alpha 2 beta 2 87PRO) or Hb S (or alpha 2 beta 2 6VAL). … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
5
1

Year Published

1998
1998
2024
2024

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 20 publications
(6 citation statements)
references
References 8 publications
0
5
1
Order By: Relevance
“…Several founder effects have been reported on the island. 27,28 Given the high prevalence of diabetes in Malta, coupled to the reported differences in MODY across European latitudes and the high propensity for founder effects in a small island population, evaluating the molecular genetics of the disease is an important exercise with both clinical and public health implications.…”
Section: Discussionmentioning
confidence: 99%
“…Several founder effects have been reported on the island. 27,28 Given the high prevalence of diabetes in Malta, coupled to the reported differences in MODY across European latitudes and the high propensity for founder effects in a small island population, evaluating the molecular genetics of the disease is an important exercise with both clinical and public health implications.…”
Section: Discussionmentioning
confidence: 99%
“…The Hb epidemiology of Malta permits further exploration in vivo of the genetic interactions involved because it is characterized by the relatively high frequency of the Hb F variant, Hb F-Malta-I [ G γ117(G19)His→Arg, CAT→CGT] (12) and of the β + IVS-I-6 (T→C) thalassemia mutation (13).…”
Section: Introductionmentioning
confidence: 99%
“…Such studies may offer new insights into γ→β-globin gene switching and the change in G γ: A γ-globin ratio that accompanies it, and may be the basis of therapeutic approaches in the management of the hemoglobinopathies. β-Valletta with an associated β-thal mutation has also made possible the objective study of the effect of β-thal mutations on the expression of the β-globin gene in vivo (31,32). Hb F-Sardinia occurs at a frequency of 0.144 in Malta (27), and if found in conjunction with Hb F-Malta-I, would allow an even more objective study of allelic β-, G γ-and A γ-globin gene expression.…”
mentioning
confidence: 99%